Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

160P - Perioperative and patient reported outcomes of robotic-assisted and video-assisted thoracoscopic surgery for patients with NSCLC receiving neoadjuvant immunotherapy: A real-world cohort study

Date

22 Mar 2024

Session

Poster Display session

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Shaowei Wu

Citation

Annals of Oncology (2024) 9 (suppl_3): 1-12. 10.1016/esmoop/esmoop102573

Authors

S. Wu1, H. Zhou2, C. Li2, M. Weng2, C. Li2, W. Zhan2, C. Cai2, Y. Lei2, L. Yao2

Author affiliations

  • 1 Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangzhou/CN
  • 2 Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 160P

Background

Neoadjuvant immunochemotherapy (Neo-IC) followed by radical resection has become the first-line therapy for local advanced wild-type non-small cell lung cancer (NSCLC), which also increases the complexity of the operation due to the therapy-related tissue texture change or general adhesion. Robotic-assisted thoracoscopic surgery (RATS) has become increasingly applied but the comprehensive safety and feasibility concerning life quality for this population is not yet to be analyzed.

Methods

A retrospective analysis was conducted for NSCLC patients who underwent either RATS or video-assisted thoracoscopic lobectomy (VATS) following Neo-IC at a single institution between October 2019 and October 2023. We analyzed and compared the clinical characteristic and perioperative outcome between RATS and VATS. The Patient Reported Outcome (PRO) was prospectively collected in a subset of the cohort for further analysis.

Results

A total of 246 cases (94 RATS, 152 VATS) were included. Of these, 138 of 246 (56.1%) patients had a major pathological response, and 97 (39.4%) had a pathological complete response based on pathological examination of surgical specimen. No significant differences were found in age, gender, BMI, clinical stage, ASA grade, conversion rate, chest tube duration and intraoperative blood loss between two groups. RATS were significantly associated with more N2 station dissected (p = 0.018), and reduced postoperative length of stay (p = 0.006). In the PRO data we found more severe chest pain was reported by VATS group during hospitalization (p = 0.027), but after discharge RATS group reported more severe cough (p = 0.012) and disturbed sleep (p = 0.025).

Conclusions

Patients receiving Neo-IC in this real-world study exhibited promising pathological remission rates. RATL demonstrated comparable safety and feasibility, with superior perioperative outcomes compared to VATL approaches. However, a more extended dissection of mediastinal lymph nodes might be associated with chronic cough, which impaired the long-term life quality.

Legal entity responsible for the study

Department of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangdong, China.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.